Market capitalization | $3.42b |
Enterprise Value | $5.60b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 96.54 |
EV/Sales (TTM) EV/Sales | 0.94 |
P/S ratio (TTM) P/S ratio | 0.57 |
P/B ratio (TTM) P/B ratio | 1.09 |
Dividend yield | 5.06% |
Last dividend (FY24) | $1.00 |
As a Free StocksGuide user, you can view scores for all 6,876 stocks worldwide.
18 Analysts have issued a Huntsman Corporation forecast:
18 Analysts have issued a Huntsman Corporation forecast:
Sep '24 |
+/-
%
|
||
Revenue | 5,987 5,987 |
6%
6%
|
|
Gross Profit | 830 830 |
12%
12%
|
|
EBITDA | 321 321 |
29%
29%
|
EBIT (Operating Income) EBIT | 37 37 |
72%
72%
|
Net Profit | -107 -107 |
232%
232%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Huntsman Corp. engages in the manufacturing of chemicals for the plastics, automotive and construction industries. It operates through the following segments: Polyurethanes, Performance Products, Advanced Materials, and Textile Effects. The Polyurethanes segment manufactures and markets polyurethane chemicals, including MDI products, PO, polyols, PG, TPU, aniline, and MTBE. The Performance Products segment produces and sells amines, surfactants, LAB, and maleic anhydride to a variety of consumer and industrial end markets. The Advanced Materials segment provides basic liquid and solid epoxy resins, specialty resin compounds, cross linking, matting and curing agents, epoxy, acrylic, and polyurethane based polymer products. The Textile Effects segment consists market share for textile chemicals and dyes. Its products include Methoxypropylamine, Isocyanate, Nonylphenol, and Alkylalkanolamines. The company was founded by Jon Meade Huntsman Sr. in 1970 and is headquartered in The Woodlands, TX.
Head office | United States |
CEO | Peter Huntsman |
Employees | 6,000 |
Founded | 1970 |
Website | www.huntsman.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.